Bilirubin

Return to HIV Research Document Library

Category Legend

Study Type(s)

Topic Area(s)

Document Type(s)

Study Method(s)

Document Method(s)

PROBeX: Blood Results Eligibility Confirmation CRF (1273)

PROBeX CRF TB/Coinfection Studies PROBeX Eligibility HIV Testing Collection Results Drug Specimen ART Treatment Africa Tuberculosis Diagnosis Blood XDR Resistance Bedaquiline Genetic Mechanisms Interactions Pharmakinetic Synthesis Medications Ritonavir Lopinavir Creatinine ALT Bilirubin Haemoglobin FBC Platelets Chemistry Potassium Albumin ALP TSH Lactate International 2020 PRO-Document Methods Clinical Community Health Immunology Virology Genetics Clinical Prospective Cohort Study Quantitative Clinical

PROBeX study eligibility from blood results CRF.

PROBeX: Eligibility Conformation CRF (1272)

PROBeX CRF TB/Coinfection Studies PROBeX Eligibility HIV Testing Criteria Enrollment Drug Inclusion Exclusion ART Treatment Africa Tuberculosis Age Diagnosis XDR Resistance Bedaquiline Genetic Mechanisms Interactions Pharmakinetic Synthesis Medications Ritonavir Lopinavir Extra-pulmonary Creatinine Serum ALT Bilirubin International 2020 PRO-Document Methods Clinical Community Health Immunology Virology Genetics Clinical Prospective Cohort Study Quantitative Clinical

Inclusion and exclusion criteria CRF for PROBeX study.